Skip to main content
OpenTrials
Completed

NCT Number: NCT06085443

Safety and Effectiveness of an Auricular Spray

The goal of this clinical trial is to test the safety and efficacy of a medical device in subjects with cerumen in excess. The main questions it aims to answer are:

* Does the medical device induce skin irritation in the ear canal? * Does the medical device reduce obstruction of ear canal induced by excessive cerumen?

Participants will use the device in each ear, once a day, every 3 days at home. Researchers will compare the medical device group to a control group who will not use the medical device.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Age range

3 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Eurofins Dermscan Poland

Gdansk, Ul. Matuszewskiego 12, 80-288, Poland

About this study

Ocean Bio Actif Hygiène de l'oreille is a medical device class IIa indicated for the prevention of the formation of earwax plugs and consequently the pathologies linked to the accumulation of earwax (hearing loss and infection/affection of the external auditory canal).

This clinical investigation is designed to improve the quality and quantity of data available on both the safety and the efficacy of Ocean Bio-Actif, in order to confirm the safety and the efficacy of the product in a post-market environment.

The objective of the current clinical investigation is to confirm the efficacy and safety of topical application to the ear canal of Ocean Bio-Actif.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Gender: female and/or male.
  • Age:

30 to 40% having age between 3 to 12 yo, 30 to 40% between 13 to 65 yo, 30 to 40% more than 65 yo.

  • Subjects able to use the tested product.
  • Subjects having history of cerumen occlusion more than once a year with or without symptoms (reduction of hearing function, obstruction feeling of the ear canal,..).
  • Subjects having ear help system or regular users of systems such as anti-noise plugs or headsets (only for the 13yo subjects and more).
  • Subjects having a clinical score of ear canal obstruction of 2 or 3 at D0.

Exclusion criteria

  • Subjects who had chirurgical act on the mastoïde.
  • Subjects who had severe troubles of the internal ear (severe dizziness, desorientation, nausea).
  • Subjects using regularly a ear spray for washing his/her ears.
  • Subjects having a score of ear canal obstruction at 4 at D0.
  • Pregnant or nursing woman or planning a pregnancy during the study;
  • Subject who had been deprived of their freedom by administrative or legal decision or who is under guardianship;
  • Subject in a social or sanitary establishment;
  • Subject suspected to be non-compliant according to the investigator's judgment;
  • Subject with a condition or receiving a medication which, in the investigator's judgment, put the subject at undue risk;
  • Subject suffering from a severe or progressive disease.

Treatment and study plan

Ear Hygiene

Other

2 sprays in each ear, every 3 days at home

Primary outcomes

  1. Skin Irritation

    Time frame: Day0 and Day90

    To confirm the safety of the device by clinical examination by ENT specialist and scoring of the irritation of the ear canal at Day90 in comparison with basal scoring of irritation at Day0 such as:

    • 0: no irritation,
    • 1: slight irritation (located slight erythema and/or dryness),
    • 2: moderate irritation (clear erythema or dryness which may be visible on the whole treated area),
    • 3: severe irritation (serious erythema with potential oedema and/or scar).

Secondary outcomes

  1. Ear Canal Obstruction Due to Excessive Earwax

    Time frame: Day0 and Day90

    To confirm the efficacy/performance of the device for the prevention of ear obstruction in comparison to baseline (Day0) and between groups using the scoring of the obstruction of ear canal by the Investigator:

    0: no obstruction - normal and/or no significant presence of cerumen in the ear canal. The membrane is clearly visible.

    • <25% minimal, very little and mostly insignificant impacted cerumen. The tympanic membrane is visible, but with still a little bit cerumen.
    • 25-50% mild, some excessive impacted cerumen causing partial occlusion of the ear canal. The tympanic membrane is not entirely visible, quite difficult to see.
    • 50-75% moderate, moderate and excessive impacted cerumen causing partial occlusion of the ear canal. Partial to very little of the tympanic membrane is visible.
    • 75-100% severe, severe and excessive impacted cerumen causing partial or complete occlusion of the ear canal. Little if any of the tympanic membrane is visible.
  2. Hearing Function

    Time frame: Day0 and Day90

    Secondary aims: EFFICACY/PERFORMANCE PREVENTION for investigational device and for control group, in comparison to the baseline (Day0) using an audiogram (only for subjects more than 6).

    Hearing function was assessed in patients on day 0 (D0) and day 90 (D90). The mean difference in hearing function (D90 - D0), expressed in decibels (dB), was reported in a data table. A mean difference greater than +5 dB is considered a gain in hearing function, while a mean difference less than -5 dB is considered a loss in hearing function. A difference in hearing function within the range [-5 dB; +5 dB] is considered to indicate no effect on hearing function.

Sponsors and collaborators

Lead sponsor

YSLab

Industry

Registry information

Official study title

Clinical Study to Evaluate the Safety and Effectiveness of an Auricular Spray Medical Device Ear Hygiene

Important dates

Study start
2024
Primary completion
2024
Study completion
2024
First posted
Oct 17, 2023
Registry last updated
Jul 10, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.